Living Microsystems pulls in $20M for prenatal tests
Living Microsystems, a Watertown, Mass., developer of new prenatal diagnostics, raised $19.6 million in a second funding round, VentureWire reports (subscription required). The company is developing new blood tests designed to detect prenatal chromosomal and genetic defects that could complement or even one day replace amniocentesis and similar invasive tests.
The round was led by Alloy Ventures, joined by Mohr Davidow Ventures and angel funders. Living Microsystems had previously raised a total of $9 million in seed and angel funding, according to VentureWire.
Next Story: Conversation with McNamee: Three fit the bill — RIM, Palm and Apple
Previous Story: Antibiotic maker BioRelix gets $26M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
